Trexquant Investment’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Trexquant Investment’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,434	Closed	-$506K	–	1587
2023 Q2	$506K	Sell	12,434 -19,165	-61%	-$782K	0.01%	996
2023 Q1	$1.22M	Buy	+31,599	New	+$1.3M	0.03%	648
2022 Q4	–	Sell	-12,861	Closed	-$548K	–	1499
2022 Q3	$548K	Buy	+12,861	New	+$659K	0.02%	772
2021 Q3	–	Sell	-3,939	Closed	-$271K	–	1275
2021 Q2	$271K	Buy	+3,939	New	+$300K	0.02%	761
2021 Q1	–	Sell	-2,210	Closed	-$219K	–	1238
2020 Q4	$219K	Buy	+2,210	New	+$270K	0.02%	849
2020 Q3	–	Sell	-4,139	Closed	-$817K	–	1319
2020 Q2	$817K	Sell	4,139 -2,264	-35%	-$469K	0.06%	474
2020 Q1	$1.25M	Buy	+6,403	New	+$1.38M	0.09%	339
2019 Q1	–	Sell	-2,774	Closed	-$254K	–	1098
2018 Q4	$254K	Buy	2,774 +498	+22%	+$50.5K	0.02%	838
2018 Q3	$256K	Buy	+2,276	New	+$240K	0.02%	736
2017 Q3	–	Sell	-2,800	Closed	-$214K	–	867
2017 Q2	$214K	Buy	+2,800	New	+$236K	0.06%	638

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Trexquant Investment's LKFT Position: Q3 2023 in Review

Trexquant Investment sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2023, closing a stake of 12,434 shares — an estimated $506K sold.

Trexquant Investment first reported a position in LKFT in Q2 2017 and held it in 10 quarters. The position peaked at $1.25M in Q1 2020. 73 funds tracked by Wall St. Rank hold LKFT as of Q3 2023.

Trexquant Investment reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Trexquant Investment sold 12,434 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2023, an estimated $506K.
Trexquant Investment first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 10 quarters.
Trexquant Investment's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.25M in Q1 2020.
73 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2023.

Based on Trexquant Investment's 13F filing for Q3 2023, filed 13 Nov 2023.